| Wnt/β-catenin signaling: the culprit in pancreatic carcinogenesis and therapeutic resistance M Ram Makena, H Gatla, D Verlekar, S Sukhavasi, M K. Pandey, ... International journal of molecular sciences 20 (17), 4242, 2019 | 125 | 2019 |
| Activation of AMP-activated protein kinase by metformin induces protein acetylation in prostate and ovarian cancer cells L Galdieri, H Gatla, I Vancurova, A Vancura Journal of Biological Chemistry 291 (48), 25154-25166, 2016 | 90 | 2016 |
| Regulation of chemokines and cytokines by histone deacetylases and an update on histone decetylase inhibitors in human diseases HR Gatla, N Muniraj, P Thevkar, S Yavvari, S Sukhavasi, MR Makena International journal of molecular sciences 20 (5), 1110, 2019 | 84 | 2019 |
| Proteasome inhibition increases recruitment of IκB kinase β (IKKβ), S536P-p65, and transcription factor EGR1 to interleukin-8 (IL-8) promoter, resulting in increased IL-8 … B Singha, HR Gatla, S Manna, TP Chang, S Sanacora, V Poltoratsky, ... Journal of Biological Chemistry 289 (5), 2687-2700, 2014 | 68 | 2014 |
| Histone deacetylase (HDAC) inhibition induces IκB kinase (IKK)-dependent interleukin-8/CXCL8 expression in ovarian cancer cells HR Gatla, Y Zou, MM Uddin, B Singha, P Bu, A Vancura, I Vancurova Journal of Biological Chemistry 292 (12), 5043-5054, 2017 | 46 | 2017 |
| Proteasome inhibition by bortezomib increases IL-8 expression in androgen-independent prostate cancer cells: the role of IKKα S Manna, B Singha, SA Phyo, HR Gatla, TP Chang, S Sanacora, ... The Journal of Immunology 191 (5), 2837-2846, 2013 | 41 | 2013 |
| Transcriptional regulation of chemokine expression in ovarian cancer B Singha, HR Gatla, I Vancurova Biomolecules 5 (1), 223-243, 2015 | 35 | 2015 |
| IKK inhibition increases bortezomib effectiveness in ovarian cancer B Singha, HR Gatla, S Phyo, A Patel, ZS Chen, I Vancurova Oncotarget 6 (28), 26347, 2015 | 28 | 2015 |
| Epigenetic regulation of interleukin-8 expression by class I HDAC and CBP in ovarian cancer cells HR Gatla, Y Zou, MM Uddin, I Vancurova Oncotarget 8 (41), 70798, 2017 | 21 | 2017 |
| Proteasome inhibition induces IKK-dependent interleukin-8 expression in triple negative breast cancer cells: Opportunity for combination therapy MM Uddin, Y Zou, T Sharma, HR Gatla, I Vancurova PLoS One 13 (8), e0201858, 2018 | 14 | 2018 |
| Evaluating cytoplasmic and nuclear levels of inflammatory cytokines in cancer cells by western blotting HR Gatla, B Singha, V Persaud, I Vancurova Cytokine Bioassays: Methods and Protocols, 271-283, 2014 | 10 | 2014 |
| HDAC/IKK inhibition therapies in solid tumors I Vancurova, HR Gatla, A Vancura Oncotarget 8 (21), 34030, 2017 | 5 | 2017 |
| Quantitative analysis of bortezomib-induced IL-8 gene expression in ovarian cancer cells B Singha, SA Phyo, HR Gatla, I Vancurova Cytokine Bioassays: Methods and Protocols, 295-304, 2014 | 4 | 2014 |
| Methods for treating solid tumor cancers using a histone deacetylase inhibitor and an IκB kinase inhibitor I Vancurova, HR Gatla, B Singha US Patent 9,993,489, 2018 | 1 | 2018 |
| Regulation of IL-8 expression by IKK and histone deacetylases in ovarian cancer HR Gatla St. John's University (New York), 2017 | | 2017 |
| Proteasome inhibition induces IL_8 expression in triple negative breast cancer cells. MM Uddin, HR Gatla, Y Zou, I Vancurova MOLECULAR BIOLOGY OF THE CELL 27, 2016 | | 2016 |
| Histone Deacetylase (HDAC) Inhibition Induces IkB Kinase (IKK)-dependent IL-8 Expression in Ovarian Cancer Cells. HR Gatla, Y Zou, MM Uddin, B Singha, A Vancura, I Vancurova MOLECULAR BIOLOGY OF THE CELL 27, 2016 | | 2016 |
| Bcl3 has a pro-survival and pro-inflammatory function in ovarian cancer cells. Y Zou, P Bu, HR Gatla, MM Uddin, I Vancurova MOLECULAR BIOLOGY OF THE CELL 27, 2016 | | 2016 |
| Proteasome inhibition by bortezomib induces interleukin-8 expression in solid tumors. HR Gatla, B Singha, T Chang, Y Zou, M Uddin, I Vancurova MOLECULAR BIOLOGY OF THE CELL 26, 2015 | | 2015 |
| Proteasome inhibition increases expression of angiogenic chemokines in ovarian cancer cells through IKKβ, S536P‐p65 and EGR‐1 dependent pathways (935.1) B Singha, H Gatla, TP Chang, S Manna, S Sanacora, I Vancurova The FASEB Journal 28, 935.1, 2014 | | 2014 |
